Buyer & investor transaction history

Procter & Gamble acquisitions

Explore 9 reviewed acquisitions involving Procter & Gamble as the buyer or investor. Compare transaction dates, targets, values and available valuation multiples, then open any comp for its sources and calculation basis.

Coverage includes published FundComb transactions recorded under Procter & Gamble. Subsidiaries, other names and undisclosed activity may be recorded separately.

Reviewed transactions
9
With value data
6
With revenue multiples
6
Transaction years
2005–2026

Sortable transaction comps

Procter & Gamble transaction table

Filter transactions

Narrow the table without crowding the main view.

Clear all filters

Rows with reported value

6 / 9

Acquisition EV, USD

USD 8.8B

Investment EV, USD

-

Median EV / revenue

5.0x

Columns

Show columns

Select up to 12 rows across filters and pages, then share or export the set.

9 shown of 9 matching transactions. Click any transaction row for more detail.

Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately.

Select for comparison
Thorne
Control
2026-08-04 Procter & Gamble 3,800 7.6x -
Mielle Organics
Control
2023-01-11 P&G Beauty 639 5.6x 22.0x
Tula
Control
2022-01-04 P&G Undisclosed 6.7x -
Ouai Haircare
Control (100%)
2021-12-06 Procter & Gamble Undisclosed - -
Farmacy Beauty
Control (100%)
2021-11-15 Procter & Gamble 350 4.4x -
2018-07-17 P&G 250 4.5x -
2018-04-19 The Procter & Gamble Company 3,700 3.7x 17.2x
2017-11-15 Procter & Gamble 100 - -
2005-01-28 Procter & Gamble Undisclosed - -

Source coverage varies by transaction. Announced deals, minority investments and capital raises retain their own labels; an investment amount is separate from enterprise value. Read the methodology.

Values may be estimated, rumored, incomplete or derived from public information. Transaction comps are informational and should not be relied on as financial, investment or valuation advice.